2012 Annual Meeting of the Society for Neuro-Oncology

cns cancers

Bevacizumab Added to Radiation and Chemotherapy Improved Progression-free Survival in Newly Diagnosed Glioblastoma

Recently announced results of the phase III AVAglio study showed that bevacizumab (Avastin) in combination with radiation and temozolomide chemotherapy increased progression-free survival (a co-primar...

Advertisement

Advertisement



Advertisement

click me